PublizoomAward notice Supplies
Nakup zdravil - poziv2
Notice published in Slovenian. The AI analysis summarises it for you in your language.
- Public buyer
- UNIVERZITETNI KLINIČNI CENTER LJUBLJANA
Ljubljana - Place of performance
- Ljubljana
- Estimated value
- €131,997,186 excl. VAT
- Amount awarded
- €84,064,668 excl. VAT
- Planned end of contract
- 30 June 2034
likely re-tender around December 2033 - Bids received
- 8
- Procedure
- Restricted procedure
You first submit an application; only shortlisted candidates are invited to bid. - Publication
- 13 August 2026
- Notice language
- Slovenian
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Nakup zdravil v okviru DNS - POZIV2
Awarded to
- Kemofarmacija, veletrgovina za oskrbo zdravstva, d.d.
- BAYER, farmacevtska družba d.o.o.
- MEDIS, farmacevtska družba, d.o.o.
- SALUS, Veletrgovina, družba za promet s farmacevtskimi, medicinskimi in drugimi proizvodi, d.o.o.
- SANOLABOR, podjetje za prodajo medicinskih, laboratorijskih in farmacevtskih proizvodov, d.d.
- ROCHE farmacevtska družba d.o.o.
- APTA MEDICA INTERNACIONAL, družba za trženje farmacevtskih izdelkov in medicinskih pripomočkov, d.o.o.
- MEDIASI, trgovanje in trženje z medicinskim materialom d.o.o.
- PROMED trgovanje in trženje z medicinskim materialom, d.o.o.
35 lots
- SKLOP 0001: aflibercept, napolnjena injekcijska brizga, 0,165 ml
- SKLOP 0002: aflibercept, napolnjena injekcijska brizga, 0,09 ml
- SKLOP 0003: BCG cepivo proti tuberkulozi za intravezikalno uporabo, ne manj kot 300 miljonov živih BCG na 1 vialo oz. 3.000.000.000 CFU na vialo
- SKLOP 0004: beremagen geperpavek, 5000000000 PFU / 1 ml
- SKLOP 0005: bevacizumab, 25 mg / 1 ml 70%
- SKLOP 0006: ceftazidim + avibaktam, (2 g + 0,5 g) / 1 viala
- SKLOP 0007: cilastatin + imipenem + relebaktam, (500 mg + 500 mg + 250 mg) / 1 vialo
- SKLOP 0008: dinutuksimab beta, 4,5 mg / 1 ml
- SKLOP 0009: efgartigimod alfa, 20 mg / 1 ml
- SKLOP 0010: faricimab, 120 mg / 1 ml
- SKLOP 0011: folitropin alfa, 450 i.e. / 0,72 ml
- SKLOP 0012: folitropin alfa, 900 i.e. / 1,44 ml
- SKLOP 0013: fosamilceftarolin, 600 mg / 1 viala
- SKLOP 0014: glukarpidaza, 1000 e. / 1 viala
- SKLOP 0015: inebilizumab, 100 mg / 1 ml
- SKLOP 0016: inklisiran, 284 mg / 1 brizga
- SKLOP 0017: karmustin, 100 mg / 1viala
- SKLOP 0018: landiolol, 280 mg / 1 viala
- SKLOP 0019: luspatercept, 25 mg / 1 viala
- SKLOP 0020: luspatercept, 75 mg / 1 viala
- SKLOP 0021: meropenem, 2 g / 1vial
- SKLOP 0022: meropenem, 1 g / 1 viala
- SKLOP 0023: nusinersen, 12 mg / 1 viala
- SKLOP 0024: nusinersen, 28 mg/ 1 viala
- SKLOP 0025: nusinersen, 50 mg /1 viala
- SKLOP 0026: piperacilin + tazobaktam, (4 g + 0,5 g) / 1 viala
- SKLOP 0027: ravulizumab, 1.100 mg / 1 viala
- SKLOP 0028: ravulizumab, 300 mg / 1 viala
- SKLOP 0029: risankizumab, 600 mg / 1 viala
- SKLOP 0030: rituksimab 70%
- SKLOP 0031: trabektedin, 1 mg / 1 viala
- SKLOP 0032: vankomicin, 1000 mg / 1 viala
- SKLOP 0033: vankomicin, 500 mg / 1 viala
- SKLOP 0030a: rituksimab 30%
- SKLOP 0005a: bevacizumab 25 mg/1ml 30%
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €436,821
- Median
- €1,451,006
- A quarter above
- €1,876,652
Amounts awarded (excl. VAT) over the last 3 years for 7 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 562564-2026.